#1
Global provider of HA
+190
employees
100+
customers
A Montagu business
- Differentiated offering of premium biofermented pharma-grade HA of high quality and safety relying on a combination of proprietary bacteria strains, a unique know how of biofermentation processes and unmatched industrial scale production capabilities
- Leading positions in attractive niche markets with double-digit long-term growth
- Diversified customer base, characterized by long-term, often exclusive, relationships
- Defensive high-cash generating business
- Strong Management team with extensive pharmaceutical production experience
Accelerating growth and driving diversification
The focus of the value creation process is to:
- Continue to gain market share in the HA space by growing share of wallet with existing clients and executing on pipeline of opportunities with new customers
- Explore growth from co-development projects with customers for new medical HA applications and formulations, including chemically modified HA
- Extend HTL’s product portfolio to other biopolymers and biotechnologies, within new and existing therapeutic areas